Mounjaro and Colon Cancer: Evidence, Risk and Safety Guidance Written by Bolt Pharmacy Published 30/10/2025 Last Updated 21/5/2026 Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes and weight management. Recent discussions have raised questions about Mounjaro and colon cancer risk, prompting concern amongst patients and […]
